Rinninger F, Mann W A, Kaiser T, Ahle S, Meyer N, Greten H
Universität Hamburg, Krankenhaus Eppendorf, Medizinische Kernklinik und Poliklinik, Germany.
Atherosclerosis. 1998 Dec;141(2):273-85. doi: 10.1016/s0021-9150(98)00181-6.
Selective uptake of high-density lipoprotein- (HDL-) associated cholesteryl esters (CE), i.e. lipid uptake independent from particle uptake, delivers CE to the liver and steroidogenic tissues in vivo. In vitro, besides hepatocytes and steroidogenic cells many other cell types selectively take up HDL CE. Hepatic lipase (HL) stimulates the internalisation of apoprotein (apo) B-containing lipoproteins by hepatocytes independent from lipolysis. In this study the role of HL in the hepatic metabolism of apo A-I-containing lipoproteins, i.e. HDL, was investigated. HDL3 (d = 1.125-1.21 g/ml) was radiolabeled in its protein (125I) and in its CE moiety ([3H]cholesteryl oleyl ether, ([3H]CEt)). HL originated from tissue culture media of hepatoma cells and from post-heparin plasma. Human Hep 3B hepatoma cells incubated in medium containing radiolabeled HDL3. In the absence of HL, the rate of apparent HDL3 particle uptake according to the lipid tracer ([3H]CEt) was in most cases in approximately 10-fold excess on that due to the protein label (125I), indicating selective CE uptake from HDL3. Addition of HL to these incubations increased the cellular uptake of [3H]CEt and of 125I from HDL3 and quantitatively the most prominent effect was an up to approximately 2.5-fold stimulation of apparent selective CE uptake ([3H]CEt-125I). This increase in selective CE uptake was observed in the presence of tetrahydrolipstatin, an inhibitor of the catalytically active site of HL, suggesting that this HL effect is independent from lipolysis. HL binds to cell surface heparan sulfate proteoglycans. To explore the role of these molecules for the HL effect on selective CE uptake, hepatoma cells were depleted of proteoglycans or Chinese hamster ovary (CHO) cells deficient in proteoglycan synthesis were used. Proteoglycan-deficiency reduced the HL-mediated increase in selective uptake by more than 80%. To investigate if low-density lipoprotein (LDL) receptors or the LDL receptor-related protein (LRP) are involved in the HL effect on selective CE uptake, murine embryonic fibroblasts (MEF) were used which are deficient in these receptors; alternatively, monensin, an inhibitor of endocytosis was present in the medium of Hep 3B cells during the uptake assay for labeled HDL3. These experiments yielded no evidence for a role of LDL receptors or LRP in the HL-mediated increase in selective CE uptake. In summary, HL mediates an increase in HDL3 selective CE uptake by human Hep 3B hepatoma cells. This HL effect is independent from lipolysis and independent from LRP and LDL receptors. However this HL effect is susceptible to cell surface proteoglycan deficiency. The potential physiologic implication is that HL modifies HDL selective CE uptake by the liver in vivo and such an effect could play a role in reverse cholesterol transport.
高密度脂蛋白(HDL)相关胆固醇酯(CE)的选择性摄取,即独立于颗粒摄取的脂质摄取,可将CE在体内输送至肝脏和类固醇生成组织。在体外,除肝细胞和类固醇生成细胞外,许多其他细胞类型也可选择性摄取HDL CE。肝脂肪酶(HL)可刺激肝细胞内化含载脂蛋白(apo)B的脂蛋白,且与脂解作用无关。在本研究中,对HL在含apo A-I脂蛋白(即HDL)的肝脏代谢中的作用进行了研究。HDL3(密度 = 1.125 - 1.21 g/ml)的蛋白质(125I)和CE部分([3H]胆固醇油醚,[3H]CEt)被放射性标记。HL来源于肝癌细胞的组织培养基和肝素后血浆。将人Hep 3B肝癌细胞置于含放射性标记HDL3的培养基中培养。在无HL的情况下,根据脂质示踪剂([3H]CEt)测定的HDL3颗粒摄取率在大多数情况下比基于蛋白质标记(125I)的摄取率高约10倍,表明从HDL3中选择性摄取CE。向这些培养物中添加HL可增加细胞对HDL3中[3H]CEt和125I的摄取,并且在数量上最显著的作用是使表观选择性CE摄取([3H]CEt - 125I)增加约2.5倍。在存在四氢脂抑素(HL催化活性位点的抑制剂)的情况下,也观察到了选择性CE摄取的增加,这表明这种HL效应与脂解作用无关。HL与细胞表面硫酸乙酰肝素蛋白聚糖结合。为探究这些分子对HL介导的选择性CE摄取效应的作用,去除了蛋白聚糖的肝癌细胞或使用了缺乏蛋白聚糖合成的中国仓鼠卵巢(CHO)细胞。蛋白聚糖缺乏使HL介导的选择性摄取增加减少了80%以上。为研究低密度脂蛋白(LDL)受体或LDL受体相关蛋白(LRP)是否参与HL对选择性CE摄取的效应,使用了缺乏这些受体的小鼠胚胎成纤维细胞(MEF);或者,在标记HDL3的摄取试验期间,在Hep 3B细胞的培养基中加入莫能菌素(一种内吞作用抑制剂)。这些实验没有提供证据表明LDL受体或LRP在HL介导的选择性CE摄取增加中起作用。总之,HL介导人Hep 3B肝癌细胞对HDL3选择性CE摄取的增加。这种HL效应与脂解作用无关,也与LRP和LDL受体无关。然而,这种HL效应易受细胞表面蛋白聚糖缺乏的影响。其潜在的生理意义是HL在体内可改变肝脏对HDL选择性CE的摄取,且这种效应可能在胆固醇逆向转运中发挥作用。